The acute treatment of supraventricular tachycardia

Mount Sinai Journal of Medicine

Volumn 64, Issue 2, 1997, Pages 142-145

  Langan, Marie Noelle S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM;

ARTICLE; ELECTROCARDIOGRAM; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA;

ACUTE DISEASE; ADENOSINE; ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CATHETER ABLATION; DIGOXIN; DILTIAZEM; ELECTROCARDIOGRAPHY; HUMANS; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0031055805     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Kalbfleisch SJ, El-Atassi R, Calkins H, Langberg JD, Morady F. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol 1993; 21:85-89.
2. Rankin AC, Brooks R, Ruskin JN, McGovern BA. Adenosine and the treatment of supraventricular tachycardia. Am J Med 1992; 92:655-664.
3. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med 1991; 114:573-575.
4. Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol 1991; 18:891-897.